161 related articles for article (PubMed ID: 23411149)
1. Scalable technology for the extraction of pharmaceutics: outcomes from a 3 year collaborative industry/academia research programme.
Sutherland I; Thickitt C; Douillet N; Freebairn K; Johns D; Mountain C; Wood P; Edwards N; Rooke D; Harris G; Keay D; Mathews B; Brown R; Garrard I; Hewitson P; Ignatova S
J Chromatogr A; 2013 Mar; 1282():84-94. PubMed ID: 23411149
[TBL] [Abstract][Full Text] [Related]
2. Scalable Technology for the Extraction of Pharmaceutics (STEP): the transition from academic knowhow to industrial reality.
Sutherland I; Ignatova S; Hewitson P; Janaway L; Wood P; Edwards N; Harris G; Guzlek H; Keay D; Freebairn K; Johns D; Douillet N; Thickitt C; Vilminot E; Mathews B
J Chromatogr A; 2011 Sep; 1218(36):6114-21. PubMed ID: 21296355
[TBL] [Abstract][Full Text] [Related]
3. Facilitating the use of counter-current chromatography in pharmaceutical purification through use of organic solvent nanofiltration.
Rundquist E; Pink C; Vilminot E; Livingston A
J Chromatogr A; 2012 Mar; 1229():156-63. PubMed ID: 22326182
[TBL] [Abstract][Full Text] [Related]
4. Separation processes for organic molecules using SCF Technologies.
Daintree LS; Kordikowski A; York P
Adv Drug Deliv Rev; 2008 Feb; 60(3):351-72. PubMed ID: 18006179
[TBL] [Abstract][Full Text] [Related]
5. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
[TBL] [Abstract][Full Text] [Related]
6. Continuous counter-current extraction on an industrial sample using dual-flow counter-current chromatography.
van den Heuvel R; Mathews B; Dubant S; Sutherland I
J Chromatogr A; 2009 May; 1216(19):4147-53. PubMed ID: 19211107
[TBL] [Abstract][Full Text] [Related]
7. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
8. [Advances in studies on multi-stage countercurrent extraction technology in traditional Chinese medicine].
Xie ZP; Liu XS; Chen Y; Cai M; Qu HB; Cheng YY
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(10):884-7. PubMed ID: 17655136
[TBL] [Abstract][Full Text] [Related]
9. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
[TBL] [Abstract][Full Text] [Related]
10. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Srai JS; Badman C; Krumme M; Futran M; Johnston C
J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
[TBL] [Abstract][Full Text] [Related]
11. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
12. Practical solvent system selection for counter-current separation of pharmaceutical compounds.
Dubant S; Mathews B; Higginson P; Crook R; Snowden M; Mitchell J
J Chromatogr A; 2008 Oct; 1207(1-2):190-2. PubMed ID: 18801491
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of scaling from pilot to process scale.
Ignatova S; Wood P; Hawes D; Janaway L; Keay D; Sutherland I
J Chromatogr A; 2007 Jun; 1151(1-2):20-4. PubMed ID: 17383663
[TBL] [Abstract][Full Text] [Related]
14. Organic solvents in the pharmaceutical industry.
Grodowska K; Parczewski A
Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
[TBL] [Abstract][Full Text] [Related]
15. Developing counter current chromatography to meet the needs of pharmaceutical discovery.
Sumner N
J Chromatogr A; 2011 Sep; 1218(36):6107-13. PubMed ID: 21612783
[TBL] [Abstract][Full Text] [Related]
16. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
[TBL] [Abstract][Full Text] [Related]
17. Improving drug manufacturing with process analytical technology.
Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
[TBL] [Abstract][Full Text] [Related]
18. Application of the near-infrared spectroscopy in the pharmaceutical technology.
Jamrógiewicz M
J Pharm Biomed Anal; 2012 Jul; 66():1-10. PubMed ID: 22469433
[TBL] [Abstract][Full Text] [Related]
19. Placing supercritical fluid chromatography one step ahead of reversed-phase high performance liquid chromatography in the achiral purification arena: a hydrophilic interaction chromatography cross-linked diol chemistry as a new generic stationary phase.
de la Puente ML; Soto-Yarritu PL; Anta C
J Chromatogr A; 2012 Aug; 1250():172-81. PubMed ID: 22494643
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to modelling counter-current chromatography.
Guzlek H; Baptista II; Wood PL; Livingston A
J Chromatogr A; 2010 Oct; 1217(40):6230-40. PubMed ID: 20813371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
